Results 11 to 20 of about 112,202 (290)
Pharmaceuticals, 2023 Background: Alzheimer’s disease (AD) is the most common cause of dementia, with a growing number of patients worldwide. The association between AD and treatment with drugs targeting the beta-adrenergic receptor is controversial.
Ali Alghamdi +5 more
doaj +1 more source
Self-reported and actual beta-blocker prescribing for heart failure patients: physician predictors. [PDF]
PLoS ONE, 2009 Beta-blockers reduce mortality among patients with systolic heart failure (HF), yet primary care provider prescription rates remain low.To examine the association between primary care physician characteristics and both self-reported and actual ...
Sanjai Sinha +3 more
doaj +1 more source
Beta blockers in traumatic brain injury: a systematic review and meta-analysis
Trauma Surgery & Acute Care Open, 2023 Background Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Beta blockers have shown promise in improving mortality and functional outcomes after TBI. The aim of this article is to synthesize the available clinical data on
Andrew Chen +5 more
doaj +1 more source
BMC Medicine, 2020 Background Beta-blockers are widely used for many cardiovascular conditions; however, their efficacy in contemporary clinical practice remains uncertain.
Oliver J. Ziff +6 more
doaj +1 more source
Inappropriate use of beta-blockers among medical and dental students at King Saud University, Riyadh
Journal of Family Medicine and Primary Care, 2020 Aim: Self-medication and inappropriate beta-blocker use have been commonly reported among students. This study aimed to determine the prevalence of inappropriate self-prescription of beta-blockers among medical and dental students.
Abdulelah Adnan Abukhalaf +6 more
doaj +1 more source
BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
Рациональная фармакотерапия в кардиологии, 2015 Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented. The role of beta-blockers among other basic groups of antihypertensive drugs (thiazide diuretics, calcium channel blockers, ACE inhibitors) is evaluated ...
M. V. Leonova
doaj +3 more sources
Ukrainian Scientific Medical Youth Journal, 2022 the article presents the results of the study of impact of the reimbursement program “Affordable medicines” on consumption of beta-blockers in Ukraine, used for treatment of cardiovascular diseases.
Anton Gonchar, Natalia Sholoiko
doaj +1 more source
Open Access Macedonian Journal of Medical Sciences, 2019 Understanding the mechanisms of cancer immune-tolerance is one of the most important challenges. Several studies have demonstrated the potential anticarcinogenic effects of beta-blockers, in patients with prostate cancer, breast cancer, and melanoma.
Petar Vojvodic +11 more
openaire +4 more sources
Journal of Pharmacoeconomics and Pharmaceutical Management, 2021 Background: Beta-blockers are preferred anti-hypertensive for patients with compelling indications. Vasodilator beta-blockers are of particular benefit in blood pressure control and other cardio-metabolic components with limited disturbance in metabolic
Mende Mensa Sorato +2 more
doaj
BMC Cardiovascular Disorders, 2021 Background The aim of this study was to determine the difference in effects of beta-blockers on long-term clinical outcomes between ischemic heart disease (IHD) patients with mid-range ejection fraction (mrEF) and those with reduced ejection fraction ...
Jun Shitara +12 more
doaj +1 more source